STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ENLV ENLIVEX THERAPEUTICS LIMITED StockScouter® Report
6
StockScouter® Score
ENLIVEX THERAPEUTICS LIMITED, a micro cap company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
Concerns
- Shares are being sold by financial institutions. Slightly negative for a small company like ENLV
- Short-term relative price momentum exhibits moderate weakness. Neutral/Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
A
C
N/A
B